NOVT Stock Overview
Provides precision medicine and manufacturing, medical solutions, and robotics and automation solutions in the United States and internationally.
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 4/6 |
| Past Performance | 2/6 |
| Financial Health | 3/6 |
| Dividends | 0/6 |
Novanta Inc. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | US$164.66 |
| 52 Week High | US$187.61 |
| 52 Week Low | US$111.20 |
| Beta | 1.35 |
| 1 Month Change | 7.54% |
| 3 Month Change | 4.01% |
| 1 Year Change | 2.16% |
| 3 Year Change | 20.29% |
| 5 Year Change | 109.46% |
| Change since IPO | 933.15% |
Recent News & Updates
Recent updates
Investors Still Waiting For A Pull Back In Novanta Inc. (NASDAQ:NOVT)
May 08
Novanta (NASDAQ:NOVT) Has Some Way To Go To Become A Multi-Bagger
Feb 24Does Novanta (NASDAQ:NOVT) Have A Healthy Balance Sheet?
Feb 05Getting In Cheap On Novanta Inc. (NASDAQ:NOVT) Is Unlikely
Dec 29Why Novanta Inc. (NASDAQ:NOVT) Could Be Worth Watching
Nov 20Here's Why We Think Novanta (NASDAQ:NOVT) Is Well Worth Watching
Nov 01Does This Valuation Of Novanta Inc. (NASDAQ:NOVT) Imply Investors Are Overpaying?
Oct 19Novanta (NASDAQ:NOVT) Seems To Use Debt Quite Sensibly
Sep 21Return Trends At Novanta (NASDAQ:NOVT) Aren't Appealing
Sep 06What Does Novanta Inc.'s (NASDAQ:NOVT) Share Price Indicate?
Aug 19Here's Why We Think Novanta (NASDAQ:NOVT) Is Well Worth Watching
Jul 16Slowing Rates Of Return At Novanta (NASDAQ:NOVT) Leave Little Room For Excitement
Jun 06These 4 Measures Indicate That Novanta (NASDAQ:NOVT) Is Using Debt Reasonably Well
May 16Should You Investigate Novanta Inc. (NASDAQ:NOVT) At US$156?
Apr 13Here's Why We Think Novanta (NASDAQ:NOVT) Is Well Worth Watching
Mar 29Investors Met With Slowing Returns on Capital At Novanta (NASDAQ:NOVT)
Feb 27These 4 Measures Indicate That Novanta (NASDAQ:NOVT) Is Using Debt Safely
Feb 12Is Novanta Inc. (NASDAQ:NOVT) Potentially Undervalued?
Jan 12We Ran A Stock Scan For Earnings Growth And Novanta (NASDAQ:NOVT) Passed With Ease
Dec 28Is Novanta (NASDAQ:NOVT) Using Too Much Debt?
Nov 02What Does Novanta Inc.'s (NASDAQ:NOVT) Share Price Indicate?
Oct 03With EPS Growth And More, Novanta (NASDAQ:NOVT) Makes An Interesting Case
Sep 19Novanta Inc. (NASDAQ:NOVT) Shares Could Be 31% Above Their Intrinsic Value Estimate
Aug 23Novanta Non-GAAP EPS of $0.78 beats by $0.06, revenue of $215.34M beats by $6.27M, raises FY guidance
Aug 09Novanta (NASDAQ:NOVT) Could Easily Take On More Debt
Aug 03Here's What To Make Of Novanta's (NASDAQ:NOVT) Decelerating Rates Of Return
Jul 11At US$124, Is Novanta Inc. (NASDAQ:NOVT) Worth Looking At Closely?
Jun 09Calculating The Fair Value Of Novanta Inc. (NASDAQ:NOVT)
May 10Novanta (NASDAQ:NOVT) Seems To Use Debt Rather Sparingly
Apr 22Returns On Capital At Novanta (NASDAQ:NOVT) Paint A Concerning Picture
Apr 03Is It Time To Consider Buying Novanta Inc. (NASDAQ:NOVT)?
Feb 21Does This Valuation Of Novanta Inc. (NASDAQ:NOVT) Imply Investors Are Overpaying?
Feb 04Returns On Capital At Novanta (NASDAQ:NOVT) Paint A Concerning Picture
Dec 21Is Novanta (NASDAQ:NOVT) A Risky Investment?
Nov 23Novanta (NASDAQ:NOVT) Has More To Do To Multiply In Value Going Forward
Sep 16Is Now The Time To Put Novanta (NASDAQ:NOVT) On Your Watchlist?
Aug 25Shareholder Returns
| NOVT | US Electronic | US Market | |
|---|---|---|---|
| 7D | -1.9% | 2.3% | 1.2% |
| 1Y | 2.2% | 25.7% | 27.7% |
Return vs Industry: NOVT underperformed the US Electronic industry which returned 25.7% over the past year.
Return vs Market: NOVT underperformed the US Market which returned 27.7% over the past year.
Price Volatility
| NOVT volatility | |
|---|---|
| NOVT Average Weekly Movement | 4.2% |
| Electronic Industry Average Movement | 6.4% |
| Market Average Movement | 5.9% |
| 10% most volatile stocks in US Market | 16.2% |
| 10% least volatile stocks in US Market | 2.8% |
Stable Share Price: NOVT has not had significant price volatility in the past 3 months.
Volatility Over Time: NOVT's weekly volatility (4%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1968 | 2,900 | Matthijs Glastra | www.novanta.com |
Novanta Inc., together with its subsidiaries, provides precision medicine and manufacturing, medical solutions, and robotics and automation solutions in the United States and internationally. The company operates through three segments: Precision Medicine and Manufacturing, Medical Solutions, and Robotics and Automation. The Precision Medicine and Manufacturing segment offers photonics-based solutions, including laser scanning, beam delivery, CO2 laser, solid state laser, ultrafast laser, and optical light engine products serving photonics-based applications for industrial processing, metrology, medical and life science imaging, DNA sequencing, and medical laser procedures.
Novanta Inc. Fundamentals Summary
| NOVT fundamental statistics | |
|---|---|
| Market cap | US$5.95b |
| Earnings (TTM) | US$69.29m |
| Revenue (TTM) | US$893.45m |
85.3x
P/E Ratio6.6x
P/S RatioIs NOVT overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| NOVT income statement (TTM) | |
|---|---|
| Revenue | US$893.45m |
| Cost of Revenue | US$495.77m |
| Gross Profit | US$397.69m |
| Other Expenses | US$328.40m |
| Earnings | US$69.29m |
Last Reported Earnings
Mar 29, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | 1.93 |
| Gross Margin | 44.51% |
| Net Profit Margin | 7.76% |
| Debt/Equity Ratio | 75.4% |
How did NOVT perform over the long term?
See historical performance and comparison